Correlation Between Instil Bio and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Instil Bio and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and NextCure, you can compare the effects of market volatilities on Instil Bio and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and NextCure.

Diversification Opportunities for Instil Bio and NextCure

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Instil and NextCure is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Instil Bio i.e., Instil Bio and NextCure go up and down completely randomly.

Pair Corralation between Instil Bio and NextCure

Considering the 90-day investment horizon Instil Bio is expected to generate 4.56 times more return on investment than NextCure. However, Instil Bio is 4.56 times more volatile than NextCure. It trades about 0.13 of its potential returns per unit of risk. NextCure is currently generating about -0.09 per unit of risk. If you would invest  1,393  in Instil Bio on September 3, 2024 and sell it today you would earn a total of  1,298  from holding Instil Bio or generate 93.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Instil Bio  vs.  NextCure

 Performance 
       Timeline  
Instil Bio 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Instil Bio and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Instil Bio and NextCure

The main advantage of trading using opposite Instil Bio and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Instil Bio and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios